tomkindlon , 4 hours ago US research: MENSA, a Media Enriched with Newly Synthesized Antibodies, to Identify SARSCoV2 Persistence & Latent Viral Reactivation in #LongCOVID https://www.medrxiv.org/content/10.1101/2024.07.05.24310017v1 "Combined, a total of 60% of PASC patients have a positive MENSA for SARS2, EBV, CMV, +/or HSV2 (contd)” @longcovid #PwLC #PostCovidSyndrome #LC #PASC #postcovid @covid19 #COVIDー19 #COVID19 #COVID #COVID_19 #SARSCoV2 #CovidIsNotOver #auscovid19 @auscovid19 1/
US research: MENSA, a Media Enriched with Newly Synthesized Antibodies, to Identify SARSCoV2 Persistence & Latent Viral Reactivation in #LongCOVID
https://www.medrxiv.org/content/10.1101/2024.07.05.24310017v1
"Combined, a total of 60% of PASC patients have a positive MENSA for SARS2, EBV, CMV, +/or HSV2 (contd)”
@longcovid #PwLC #PostCovidSyndrome #LC #PASC #postcovid @covid19 #COVIDー19 #COVID19 #COVID #COVID_19 #SARSCoV2 #CovidIsNotOver #auscovid19 @auscovid19 1/
tomkindlon OP , 4 hours ago 2/ “MENSA offers a unique antibody snapshot to reveal the underlying viral drivers in #longCOVID thus demonstrating the persistence of SARS2 and reactivation of viral herpes in 60% of PASC patients." #PwLC #PostCovidSyndrome #LC #PASC #postcovid @longcovid @covid19 @auscovid19
2/
“MENSA offers a unique antibody snapshot to reveal the underlying viral drivers in #longCOVID thus demonstrating the persistence of SARS2 and reactivation of viral herpes in 60% of PASC patients."
#PwLC #PostCovidSyndrome #LC #PASC #postcovid @longcovid @covid19 @auscovid19